HealthCare Global

What HealthCare Global does

HealthCare Global Enterprises Limited (NSE: HCG) is India's largest dedicated specialty oncology hospital network, operating 25 comprehensive cancer hospitals across 21 cities plus an international centre — HCG CCK Cancer Centre in Nairobi, Kenya — supported by 2,500+ beds and a workforce of 5,001-10,000 employees that includes 400+ oncologists. The company delivers end-to-end adult and pediatric cancer care spanning preventive oncology (Silver/Gold Cancer Screening packages), diagnosis (genomics, molecular diagnostics, digital pathology, PET-CT, 3T MRI), and treatment modalities including medical oncology, surgical oncology, hemato-oncology and bone marrow transplant, paediatric oncology, CAR T-cell therapy, liver transplantation, and supportive services (psycho-oncology, nutrition, palliative care, rehabilitation). The technology backbone includes network-wide deployment of Elekta Unity MR-LINAC, Varian Halcyon/Ethos/TrueBeam/TomoTherapy, Siemens PET-CT, Accuray CyberKnife, Intuitive da Vinci surgical systems, Microsoft HoloLens 2 mixed reality, and in-house genomics and molecular diagnostics — with HCG having been first in India to deploy the Agility Synergy linear accelerator and first in Karnataka to deploy the Elekta Unity MR-LINAC.

HCG's business model is anchored on per-treatment and per-procedure pricing for inpatient, outpatient, surgical, ICU, and day-care chemotherapy services delivered through owned facilities, supplemented by fixed-price preventive oncology packages, dedicated international patient services, and clinical research collaborations (e.g., ErlySign saliva-based oral cancer detection). Revenue is generated via a hybrid direct-to-consumer and enterprise field-sales motion: doctor referrals, corporate partnerships, a 24/7 helpline (+91-7406499999), online appointment booking, the HCG Care mobile app, and WhatsApp-driven patient acquisition. Government health schemes (CGHS, ECHS, and state schemes) have historically contributed a meaningful share of revenue at top private hospitals (~25% sector-wide), but HCG is re-evaluating participation due to payment delays, low reimbursements, and pricing caps, including a 25-day Vizag disruption tied to a state-scheme dispute. In January 2026, KKR acquired a 54% controlling stake for USD 400 million, and in May 2026 the company opened a new 110-bed, ₹130 crore flagship cancer hospital in north Bengaluru with Karnataka's first Elekta Unity MR-LINAC, underscoring continued capital-led expansion under PE ownership.

Name

HealthCare Global

Legal name

HealthCare Global Enterprises Limited

Website

https://www.hcgoncology.com/

Company type

Public

Founded year

1989

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

HealthCare Global (HCG) operates India's largest dedicated oncology hospital network, with 25 comprehensive cancer hospitals across 21 cities plus a centre in Nairobi, Kenya, delivering medical, surgical, and radiation oncology to adult and pediatric cancer patients using advanced technologies including CyberKnife, da Vinci robotics, Elekta Unity MR-LINAC, and genomics-enabled precision oncology.

Ownership category

akta.pro rank

Product category

Specialty Oncology Hospital Services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (622310)

SIC

Services-General Medical & Surgical Hospitals, Nec (8062)

akta.pro primary industry

Oncology & Cancer Specialty Hospitals (HLAFAHAC)

akta.pro secondary industries

Medical Oncology (HLAKAFAB), Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI)

Keywords

• Oncology hospital services
• Cancer treatment services
• Radiation oncology
• Surgical oncology
• Cancer screening packages

Headquarters

HQ city

Bangalore

HQ country

India

HQ region

Asia

Offices23 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. Hospital and clinical services revenue: Primary revenue from cancer treatment services (medical oncology, surgical oncology, radiation oncology, hemato-oncology and BMT, paediatric oncology, organ-specific oncology) delivered across 25 comprehensive cancer hospitals and day-care chemotherapy centres in India, plus HCG CCK Cancer Centre in Nairobi, Kenya. Includes inpatient, outpatient, ICU, surgical, and ICU services tied to per-treatment and per-procedure pricing. Government health schemes (CGHS, ECHS, and state schemes) historically account for a portion of revenue (~25% sector-wide) and are being re-evaluated due to payment delays, low reimbursements, and pricing caps.
2. Preventive health checkup packages: Recurring/packaged preventive oncology services offered as fixed-price Cancer Screening packages in Male and Female Silver and Gold tiers, plus Cancer Preventive Packages at Aastha Ahmedabad, Borivali Mumbai, and KR Road Bangalore. Includes screening, sample collection, and reporting.
3. International patient services: Dedicated revenue stream from international patients seeking cancer treatment in India, supported by International Patient Services team, dedicated helpline (+91-9742263629), email ([email protected]), and HCG CCK Cancer Centre in Nairobi, Kenya.
4. Clinical research and diagnostics collaborations: Revenue/advisory contribution from clinical trial collaborations with diagnostic and biotech startups (e.g., ErlySign saliva-based oral cancer detection kit clinical trials across ~1,000 patients at HCG and Regional Cancer Hospital).

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels8 records

Core offering

HealthCare Global (HCG) operates India's largest dedicated oncology hospital network, delivering comprehensive cancer care across 25 comprehensive cancer hospitals in 21 Indian cities plus an international centre in Nairobi, Kenya. Core offerings span preventive cancer screening, diagnostics, medical oncology (chemotherapy, immunotherapy, CAR T-cell therapy), surgical oncology (robotic and laparoscopic), radiation oncology (CyberKnife, Elekta Unity MR-LINAC, Varian and TomoTherapy platforms), hemato-oncology and bone marrow transplant, paediatric oncology, and supportive/palliative care, supported by in-house genomics and molecular diagnostics. The company also offers fixed-price cancer screening packages (Male/Female Silver and Gold tiers), international patient services, second-opinion services, and the HCG Care mobile app for patient engagement.

Differentiator

Problem solved

Functional benefit

Brands

• HCG Care: Patient-friendly mobile application for personalized cancer care, enabling appointment booking, medicine ordering, sample collection, and health record management.
• Pink Hope

Products and services

• Medical Oncology Systemic cancer treatment service covering chemotherapy, immunotherapy, hormone therapy, targeted therapy, and day-care chemotherapy for adult and paediatric oncology patients across HCG's 25-hospital network in India and Nairobi.
• Radiation Oncology Radiation therapy service delivered across HCG's network using CyberKnife, Elekta Unity MR-LINAC, Varian Halcyon/TrueBeam/Ethos/TomoTherapy, Siemens linear accelerators, brachytherapy (Iridium-192, Iodine-125, Palladium-103), Ethos Adaptive Radiation Therapy, RapidArc, and Hyperthermia — for precise tumour targeting with reduced damage to healthy tissue.
• Surgical Oncology Surgical cancer treatment service covering robotic-assisted oncosurgery (da Vinci Surgical System, MP1000B surgical robot), day-care oncosurgery, reconstructive surgery, oral & maxillofacial surgery, hepatobiliary surgery, and gynaecologic, breast, thoracic, gastrointestinal, uro, and orthopaedic oncology surgery across the HCG network.
• Bone Marrow Transplant (BMT) Hemato-oncology and bone marrow transplant service for adult and paediatric patients across HCG's network, complementing CAR T-cell therapy, hematology, and paediatric haematology oncology offerings.
• CAR T-Cell Therapy Chimeric antigen receptor T-cell therapy service for eligible hematologic and oncologic indications, delivered across HCG's hemato-oncology and bone marrow transplant programme.
• Cancer Screening Services Preventive cancer screening service for early detection of breast, cervical, prostate, colorectal, lung, and oral cancers; offered as fixed-price Male and Female Cancer Screening packages in Silver and Gold tiers plus Cancer Preventive Packages at Ahmedabad, Mumbai, and Bengaluru.
• Paediatric Oncology Specialised cancer care service for paediatric patients covering paediatric haematology oncology, BMT, chemotherapy, and supportive care, delivered through HCG's multidisciplinary paediatric oncology programme.
• International Patient Services Dedicated cross-border patient coordination service for international cancer patients seeking treatment in India or at HCG's Nairobi centre, including visa support, language coordination, second-opinion services, treatment planning, and continuity of care.
• Second Opinion Service Online second-opinion service where cancer patients can submit reports for initial advisory review, with specific clinical advice following in-person examination by HCG's oncologists.
• HCG Care Mobile Application HCG Care mobile application (available on Google Play and Apple App Store) enabling patients to book appointments, order medicines, schedule sample collection, and manage health records across HCG's hospital network.
• Day Care Chemotherapy Centre Day-care chemotherapy service delivered at HCG's outpatient centres in Bengaluru (Banashankari, Kalyan Nagar, Malleshwaram) and Bhubaneswar (Jayadev Vihar), enabling chemotherapy administration without inpatient admission.
• Robotic Surgery Robotic-assisted cancer surgery service using the da Vinci Surgical System (Intuitive) and MP1000B surgical robot, enabling minimally invasive, precision-driven oncosurgery across HCG's surgical oncology programme.
• Preventive Oncology Preventive oncology service dedicated to cancer risk assessment, structured screening pathways, and early detection programmes for at-risk adults across HCG's network.
• Organ-Specific Oncology Specialised organ-specific cancer care service covering breast, gastrointestinal, gynaecologic, thoracic, uro, orthopaedic, head and neck, hepatobiliary, and other organ-site oncology programmes delivered by dedicated multidisciplinary teams across HCG's hospital network.

Quantifiable outcome

• 21 cities and 25 comprehensive cancer hospitals across India plus 1 international centre in Nairobi, Kenya
• +4 more outcomes

Named customers2 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature10 records

Partnerships

Seven partnerships are on record, tiered minor — single clinical study, core — radiation oncology equipment, core — imaging and radiation equipment, core — robotic surgery, core — stereotactic radiosurgery and minor — joint clinical study.

• ErlySign (Nagpur-based biotech startup)minor — single clinical studyStrategic or Co-development PartnerClinical trial collaboration partner for ErlySign's saliva-based oral cancer detection kit across approximately 1,000 patients at Healthcare Global and Regional Cancer Hospital. Trial demonstrated 98% sensitivity and 100% specificity, supporting ErlySign's US FDA Breakthrough Device Designation — India's first saliva-based, non-invasive diagnostic for oral precancerous conditions.
• Elektacore — radiation oncology equipmentTechnology or IntegrationHCG deploys Elekta Unity MR-LINAC (Karnataka's first, in new north Bengaluru hospital), Elekta Harmony Pro, and Elekta Microselectron Digital linear accelerators across its radiation oncology network.
• Varian (a Siemens Healthineers company)core — radiation oncology equipmentTechnology or IntegrationHCG deploys multiple Varian linear accelerators including Varian Halcyon, Varian Unique Power, TrueBeam Edge, Ethos Adaptive Radiation Therapy, VitalBeam, and Versa HD across its cancer hospitals.
• Siemens Healthineerscore — imaging and radiation equipmentTechnology or IntegrationHCG uses Siemens Artiste M5772 linear accelerator, Siemens Biograph Horizon PET-CT, Siemens ONCOR linear accelerator, and Skyra 3T MRI (Siemens) across its diagnostic and radiation oncology services.
• Intuitive (da Vinci Surgical System)core — robotic surgeryTechnology or IntegrationHCG uses the da Vinci Surgical System for robotic-assisted surgical oncology, supplemented by robotic-assisted modular operating theatres at the new north Bengaluru cancer hospital.
• Accuray (CyberKnife)core — stereotactic radiosurgeryTechnology or IntegrationHCG offers CyberKnife robotic radiosurgery, TomoTherapy H, and Radixact X9 TomoTherapy across its precision radiation oncology portfolio.
• Regional Cancer Hospitalminor — joint clinical studyStrategic or Co-development PartnerCo-collaborator with HCG on the ErlySign saliva-based oral cancer detection clinical trials across approximately 1,000 patients.

Scale indicators10 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Apollo Hospitals Enterprise: India's largest hospital chain operating comprehensive cancer centres with medical, surgical, and radiation oncology; directly competes with HCG for tertiary cancer patients across most Indian metros where both have a footprint.
• Max Healthcare Institute: Premium hospital chain with strong oncology programmes in North India, including advanced radiation and surgical oncology; competes with HCG for high-acuity cases and doctor talent.
• Cytecare Hospitals: India-based single-specialty oncology hospital chain offering medical, surgical, and radiation oncology; directly comparable pure-play oncology network model that competes with HCG in select metros.
• Manipal Hospitals: Large pan-India hospital network (recently expanded via the USD 700M Sahyadri acquisition) with growing oncology service lines; competes with HCG in Karnataka, Maharashtra, and other southern/western India markets.
• Aster DM Healthcare: India-GCC hospital operator with growing oncology presence (recently merged with Quality Care India); cited alongside HCG in notable Indian healthcare M&A activity and competes for international and Indian cancer patients.
• Fortis Healthcare: Multi-specialty private hospital operator with dedicated oncology programmes (medical, surgical, radiation) across India; competes head-to-head with HCG for oncology patients, doctors, and advanced-technology procurement.
• Medanta (Global Health): Multi-specialty hospital group with dedicated cancer institute offering medical, surgical, and radiation oncology; competes with HCG particularly in North India for tertiary cancer patients.
• Narayana Health: Pan-India affordable hospital chain with expanding oncology and cardiac-oncology services; competes with HCG for value-conscious oncology patients, particularly in southern and eastern India.

Regional players

• KIMS Hospitals (Kerala Institute of Medical Sciences): South-Indian hospital chain with oncology programmes; comparable specialty hospital operator with similar regional Indian footprint, though concentrated more in Kerala and Telugu-speaking states.

Broad incumbents

• Tata Memorial Hospital (TMC / ACTREC): Premier government-funded cancer hospital and research centre in Mumbai; not a private peer but the dominant reference benchmark in Indian oncology and a major source of referrals and trained oncologists.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat7 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/HCGCyberknife
• YouTubeyoutube.com/@TheHcgOncology
• Facebookfacebook.com/HCGHospitals?mibextid=LQQJ4d
• LinkedInlinkedin.com/company/healthcare-global
• Instagraminstagram.com/hcgoncology

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds3 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about HealthCare Global